Get the app!
Back to Trades

Payton Lori

Chief Development OfficerCIK 0002144768

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Payton Lori, Chief Development Officer, has filed 1 SEC report (2026), all concentrated in Yarrow Bioscience, Inc. (YARW), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Jul 29YARW
Yarrow Bioscience, Inc.
Payton LoriChief Development OfficerOther$0

1 filing